Surgical treatment of pancreatic head cancer and perioperative management in high thromboembolic risk patients with recent drug-eluting coronary stent implantation

Takahisa Fujikawa, Yasunori Yoshimoto, Akira Tanaka

Abstract


Patients with multiple coronary artery diseases, especially with recent implantation of a drug-eluting coronary stent (DES), require strong dual antiplatelet therapy and regarded as those with very high thromboembolic risks. When these patients undergo major abdominal surgery for malignancy, perioperative risks including bleeding and thromboembolic risks have to be balanced against oncological radicality. We performed successful management of 81-year-old man suffering locally advanced pancreatic head cancer detected just after recent DES implantation. Curative-intent pancreaticoduodenectomy under preoperative continuation of aspirin monotherapy is safe and feasible, and is considered to be one of the promising options for the treatment of such complicated patients.

Keywords


pancreatic head cancer; high thromboembolic risk; drug-eluting coronary stent implantation; dual antiplatelet therapy; perioperative management

References


Fujikawa T, Tanaka A, Abe T, et al. Effect of antiplatelet therapy on patients undergoing gastroenterological surgery: Thromboembolic risks versus bleeding risks during its perioperative withdrawal. World J Surg 2015;39:39-149.

Fujikawa T, Tanaka A. Successful multidisciplinary treatment of hilar cholangiocarcinoma in a patient with complicated new-onset coronary artery disease. BMJ Case Rep 2014. doi:10.1136/bcr-2014-203941.

Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. Circuration 2007;115:813-818.

Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.

Thachil J, Gatt A, Martlew V. Management of surgical patients receiving anticoagulation and antiplatelet agents. Br J Surg 2008;95:1437-1448.

Fujikawa T, Tanaka A, Abe T, Yoshimoto Y, Tada S, Maekawa H, Shimoike N. Does antiplatelet therapy affect outcomes of patients receiving abdominal laparoscopic surgery? Lessons from more than 1,000 laparoscopic operations in a single tertiary referral hospital. J Am Coll Surg 2013;217:1044-1053.


Full Text: PDF HTML

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.